Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS.
Moreover presence of insulin resistance and diabetes are risk factors for fibrosis progression and nonresponse to antiviral therapy in chronic hepatitis C (CHC).
Earlier today, October 5, 2020, Rice was informed that he had won the Nobel Prize in Physiology or Medicine for the discovery of the virus that causes hepatitis C.
And if you're an adult who hasn't been screened for hepatitis C, consider talking to your doctor about testing options, as too many people don't realize they have it.